Crestchem Limited - Due diligence report

A 360° intelligence report on Crestchem: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…

1991-04-26 Indrad, Gujarat Active Listed Active Compliant
Share
Connect MCP
CL Crestchem Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Crestchem — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Crestchem is assessed as Low Risk with a Trust Score of 83/100. Crestchem is an active public limited indian non-government company incorporated in 1991, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Crestchem Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
56/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 56/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: BSE.
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
DIPAK NARENDRAPRASAD PATEL 01234567 Director 01/04/2018 6 yrs Approved
NIRMIT DIPAK PATEL 01234567 Director 01/04/2018 6 yrs Approved
BINABEN PARASBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
JIGNESH ASHVINKUMAR SHAH 01234567 Director 01/04/2018 6 yrs Approved
RAJESH ISHWARLAL MODY 01234567 Director 01/04/2018 6 yrs Approved
KHYATI DIPAKKUMAR VYAS 01234567 Director 01/04/2018 6 yrs Approved
MANOJKUMAR BABUBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
RINKAL MAULIK JASANI 01234567 Director 01/04/2018 6 yrs Approved
Priyankaben Manojkumar Patel 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 2 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: DIPAK NARENDRAPRASAD PATEL (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
Operating for 35+ years.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (56/100).
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
21 Aug 2025
Last AGM held
Annual general meeting
28 May 2025
Director appointed
RINKAL MAULIK JASANI (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
04 Jul 2024
Director appointed
Priyankaben Manojkumar Patel (Director)
29 Dec 2023
Director appointed
JIGNESH ASHVINKUMAR SHAH (Director)
17 Jul 2023
Director appointed
NIRMIT DIPAK PATEL (Director)
01 Apr 2022
Director appointed
MANOJKUMAR BABUBHAI PATEL (Director)
01 Apr 2020
Director appointed
KHYATI DIPAKKUMAR VYAS (Company Secretary)
29 Sep 2018
Director ceased
NITINKUMAR SHANTILAL SHAH
31 Mar 2017
Share transfer (FY 2017)
100.00000000 shares to SADHANA
14 Aug 2016
Director ceased
NEIL DARSHAN DALAL
31 Mar 2016
Share transfer (FY 2016)
100.00000000 shares to ROOPLATHA
07 Nov 2015
Director ceased
NARENDRAKUMAR HARIBHAI PATEL
25 Mar 2015
Director appointed
BINABEN PARASBHAI PATEL (Director)
30 Jan 2015
Director ceased
HARENDRA LILADHAR JOSHI
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
9 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Almega Paints Private Limited U24220MH2008PTC183058 Mumbai, Maharashtra, India
Beryl Drugs L02423MP1993PLC007840 Indore, Madhya Pradesh, India
Nutribray Healthcare Private Limited U24290HR2021PTC100232 Gurgaon, Haryana, India
Alkali Metals L27109TG1968PLC001196 Hyderabad, Telangana, India
Link Pharma L24230GJ1984PLC007540 Baroda, Gujarat, India
Akron Parentarals Private Limited U24239AP1994PTC016773 Muppalla, Andhra Pradesh, India
D P Petrochem Private Limited U24290GJ2019PTC107895 Limda, Gujarat, India
Saraf Organics Pvt Ltd U24114MH1989PTC052696 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Crestchem before audits and certifications: compliance score 56/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Crestchem: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Crestchem - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Crestchem pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Crestchem - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Crestchem an active company?

Crestchem has MCA status “Active” with a compliance score of 56/100 (Moderate).

Is Crestchem financially healthy?

Crestchem has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Crestchem?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Crestchem?

Promoters hold the largest single block of equity - exact percentages are in the full report. 9 active director(s) are on record.

Does Crestchem have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Crestchem up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 56/100 (Moderate).

Is it risky to lend to Crestchem?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.